The mRNA Revolution in Vaccines: Flu Shot Approval is Only the Beginning The recent FDA approval of Moderna's mFlusiva flu vaccine marks a significant milestone in the application of mRNA technology in vaccine development.
This breakthrough, hailed as crucial to ending the Covid 19 pandemic, has expanded to other vaccines. At its core, mRNA technology allows for rapid creation of customized vaccines tailored to specific viral strains.
Unlike traditional flu vaccines, which must be reformulated annually, mRNA based vaccines can be produced quickly and efficiently.